Characterization of suramin binding sites on the human group IIA secreted phospholipase A(2) by site-directed mutagenesis and molecular dynamics simulation


Autoria(s): Aragao, Elisangela Aparecida; Vieira, Davi Serradella; Chioato, Lucimara; Ferreira, Tatiana Lopes; Lourenzoni, Marcos Roberto; Silva, Samuel Reghim; Ward, Richard John
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

22/10/2013

22/10/2013

2012

Resumo

Suramin is a polysulphonated naphthylurea with inhibitory activity against the human secreted group IIA phospholipase A(2) (hsPLA2GIIA), and we have investigated suramin binding to recombinant hsPLA2GIIA using site-directed mutagenesis and molecular dynamics (MD) simulations. The changes in suramin binding affinity of 13 cationic residue mutants of the hsPLA2GIIA was strongly correlated with alterations in the inhibition of membrane damaging activity of the protein. Suramin binding to hsPLA2GIIA was also studied by MD simulations, which demonstrated that altered intermolecular potential energy of the suramin/mutant complexes was a reliable indicator of affinity change. Although residues in the C-terminal region play a major role in the stabilization of the hsPLA2GIIA/suramin complex, attractive and repulsive hydrophobic and electrostatic interactions with residues throughout the protein together with the adoption of a bent suramin conformation, all contribute to the stability of the complex. Analysis of the h5PLA2GIIA/suramin interactions allows the prediction of the properties of suramin analogues with improved binding and higher affinities which may be candidates for novel phospholipase A(2) inhibitors. (C) 2012 Elsevier Inc. All rights reserved.

FAPESP [2009/13902-7, 2002/12746-2]

FAPESP

CNPq

CNPq [152669/2007-8, 504807/2009-9, 304982/2006-7]

PRPUSP

PRP-USP

Identificador

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, NEW YORK, v. 519, n. 1, supl. 4, Part 1, pp. 17-22, 36951, 2012

0003-9861

http://www.producao.usp.br/handle/BDPI/35460

10.1016/j.abb.2012.01.002

http://dx.doi.org/10.1016/j.abb.2012.01.002

Idioma(s)

eng

Publicador

ELSEVIER SCIENCE INC

NEW YORK

Relação

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Direitos

closedAccess

Copyright ELSEVIER SCIENCE INC

Palavras-Chave #PLA(2) INHIBITOR #PROTEIN-DRUG BINDING #DRUG DESIGN #MAJOR PHYSIOLOGICAL-ROLE #BACTERIAL-CELL WALL #INHIBITORS #ENZYME #ELECTROSTATICS #PENETRATION #EXPRESSION #ANALOGS #PHASE #BIOCHEMISTRY & MOLECULAR BIOLOGY #BIOPHYSICS
Tipo

article

original article

publishedVersion